PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.630
-0.010 (-0.61%)
At close: Mar 9, 2026, 4:00 PM EDT
1.622
-0.008 (-0.51%)
After-hours: Mar 9, 2026, 6:56 PM EDT
PMV Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 16.33 | 26.92 | 24.25 | 25.05 | 21.8 | |
| Research & Development | 69.88 | 57.93 | 55.89 | 51.99 | 36.49 | |
| Operating Expenses | 86.21 | 84.85 | 80.13 | 77.04 | 58.29 | |
| Operating Income | -86.21 | -84.85 | -80.13 | -77.04 | -58.29 | |
| Interest Expense | 6.34 | - | - | - | - | |
| Interest & Investment Income | - | 10.66 | 11.17 | 3.63 | 0.45 | |
| Other Non Operating Income (Expenses) | -0.05 | -0.02 | 0 | 0.09 | 0.02 | |
| EBT Excluding Unusual Items | -79.91 | -74.21 | -68.96 | -73.33 | -57.82 | |
| Merger & Restructuring Charges | - | -0.6 | - | - | - | |
| Pretax Income | -79.91 | -74.81 | -68.96 | -73.33 | -57.82 | |
| Income Tax Expense | -2.17 | -16.1 | 0 | -0.01 | 0.02 | |
| Net Income | -77.74 | -58.71 | -68.96 | -73.32 | -57.85 | |
| Net Income to Common | -77.74 | -58.71 | -68.96 | -73.32 | -57.85 | |
| Shares Outstanding (Basic) | 53 | 52 | 48 | 46 | 45 | |
| Shares Outstanding (Diluted) | 53 | 52 | 48 | 46 | 45 | |
| Shares Change (YoY) | 1.87% | 7.42% | 5.31% | 1.01% | 214.23% | |
| EPS (Basic) | -1.48 | -1.14 | -1.44 | -1.61 | -1.28 | |
| EPS (Diluted) | -1.48 | -1.14 | -1.44 | -1.61 | -1.28 | |
| Free Cash Flow | -73.61 | -51.94 | -56.62 | -71.74 | -47.92 | |
| Free Cash Flow Per Share | -1.40 | -1.01 | -1.18 | -1.57 | -1.06 | |
| EBITDA | -86.07 | -83.71 | -78.88 | -76.73 | -57.99 | |
| D&A For EBITDA | 0.13 | 1.14 | 1.26 | 0.32 | 0.31 | |
| EBIT | -86.21 | -84.85 | -80.13 | -77.04 | -58.29 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.